Drug Type Small molecule drug, Therapeutic radiopharmaceuticals |
Synonyms- |
Target- |
Mechanism Ionising radiation emitters |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Prostate Carcinoma | Phase 2 | CN | 13 Sep 2023 | |
Metastatic castration-resistant prostate cancer | Phase 1 | CN | 13 Sep 2023 | |
Metastatic Prostatic Adenocarcinoma | Phase 1 | CN | 13 Sep 2023 | |
PSMA-Positive Prostatic Cancer | IND Approval | CN | 29 Dec 2022 |